These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 28195647)

  • 1. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification.
    Sjödahl G; Eriksson P; Liedberg F; Höglund M
    J Pathol; 2017 May; 242(1):113-125. PubMed ID: 28195647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Subtype Profiling of Urothelial Carcinoma Using a Subtype-Specific Immunohistochemistry Panel.
    Sjödahl G
    Methods Mol Biol; 2018; 1655():53-64. PubMed ID: 28889377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology of the luminal class of urothelial tumors.
    Bernardo C; Eriksson P; Marzouka NA; Liedberg F; Sjödahl G; Höglund M
    J Pathol; 2019 Nov; 249(3):308-318. PubMed ID: 31232464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.
    Patschan O; Sjödahl G; Chebil G; Lövgren K; Lauss M; Gudjonsson S; Kollberg P; Eriksson P; Aine M; Månsson W; Fernö M; Liedberg F; Höglund M
    Eur Urol; 2015 Nov; 68(5):824-32; discussion 835-6. PubMed ID: 25770486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted DNA and RNA Sequencing of Paired Urothelial and Squamous Bladder Cancers Reveals Discordant Genomic and Transcriptomic Events and Unique Therapeutic Implications.
    Hovelson DH; Udager AM; McDaniel AS; Grivas P; Palmbos P; Tamura S; Lazo de la Vega L; Palapattu G; Veeneman B; El-Sawy L; Sadis SE; Morgan TM; Montgomery JS; Weizer AZ; Day KC; Neamati N; Liebert M; Keller ET; Day ML; Mehra R; Tomlins SA
    Eur Urol; 2018 Dec; 74(6):741-753. PubMed ID: 30033047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion.
    Garg M; Kanojia D; Seth A; Kumar R; Gupta A; Surolia A; Suri A
    Eur J Cancer; 2010 Jan; 46(1):207-15. PubMed ID: 19914824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort.
    Marzouka NA; Eriksson P; Rovira C; Liedberg F; Sjödahl G; Höglund M
    Sci Rep; 2018 Feb; 8(1):3737. PubMed ID: 29487377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular profiling in muscle-invasive bladder cancer: more than the sum of its parts.
    Sjödahl G; Jackson CL; Bartlett JM; Siemens DR; Berman DM
    J Pathol; 2019 Apr; 247(5):563-573. PubMed ID: 30604486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours: An integrated immunohistochemical analysis.
    Bernardo C; Eriksson P; Marzouka NA; Liedberg F; Sjödahl G; Höglund M
    Hum Pathol; 2022 Apr; 122():11-24. PubMed ID: 35108518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems.
    Eriksson P; Aine M; Veerla S; Liedberg F; Sjödahl G; Höglund M
    BMC Med Genomics; 2015 May; 8():25. PubMed ID: 26008846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Subtypes of Urothelial Bladder Cancer: Results from a Meta-cohort Analysis of 2411 Tumors.
    Tan TZ; Rouanne M; Tan KT; Huang RY; Thiery JP
    Eur Urol; 2019 Mar; 75(3):423-432. PubMed ID: 30213523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lund taxonomy for bladder cancer classification - from gene expression clustering to cancer cell molecular phenotypes, and back again.
    Höglund M; Bernardo C; Sjödahl G; Eriksson P; Axelson H; Liedberg F
    J Pathol; 2023 Apr; 259(4):369-375. PubMed ID: 36700594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The urothelial cell line UROtsa transformed by arsenite and cadmium display basal characteristics associated with muscle invasive urothelial cancers.
    Hoggarth ZE; Osowski DB; Freeberg BA; Garrett SH; Sens DA; Sens MA; Zhou XD; Zhang KK; Somji S
    PLoS One; 2018; 13(12):e0207877. PubMed ID: 30550540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of insulin receptor on tumour-associated blood vessels in invasive bladder cancer predicts poor overall and progression-free survival.
    Roudnicky F; Dieterich LC; Poyet C; Buser L; Wild P; Tang D; Camenzind P; Ho CH; Otto VI; Detmar M
    J Pathol; 2017 Jun; 242(2):193-205. PubMed ID: 28295307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy.
    Heide T; Maurer A; Eipel M; Knoll K; Geelvink M; Veeck J; Knuechel R; van Essen J; Stoehr R; Hartmann A; Altmueller J; Graham TA; Gaisa NT
    J Pathol; 2019 Jun; 248(2):230-242. PubMed ID: 30719704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternatively spliced KAI1 mRNA is expressed at low levels in human bladder cancers and bladder cancer cell lines and is not associated with invasive behaviour.
    Jackson P; Rowe A; Grimm MO
    Oncol Rep; 2007 Dec; 18(6):1357-63. PubMed ID: 17982617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
    Humphrey PA; Moch H; Cubilla AL; Ulbright TM; Reuter VE
    Eur Urol; 2016 Jul; 70(1):106-119. PubMed ID: 26996659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases.
    Sjödahl G; Eriksson P; Lövgren K; Marzouka NA; Bernardo C; Nordentoft I; Dyrskjøt L; Liedberg F; Höglund M
    Mod Pathol; 2018 Dec; 31(12):1869-1881. PubMed ID: 29967424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific micro-RNA expression patterns distinguish the basal and luminal subtypes of muscle-invasive bladder cancer.
    Ochoa AE; Choi W; Su X; Siefker-Radtke A; Czerniak B; Dinney C; McConkey DJ
    Oncotarget; 2016 Dec; 7(49):80164-80174. PubMed ID: 27845906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between expression of the KAI1 metastasis suppressor and other markers of advanced bladder cancer.
    Ow K; Delprado W; Fisher R; Barrett J; Yu Y; Jackson P; Russell PJ
    J Pathol; 2000 May; 191(1):39-47. PubMed ID: 10767717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.